| 2025-11-25 |
详情>>
内部人交易：
Lampropoulos Fred P.股份减少10000.00股
|
| 2025-10-30 |
详情>>
股本变动：
变动后总股本5929.02万股
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.53美元,归母净利润9048.30万美元,同比去年增长-2.09%
|
| 2025-10-30 |
财报披露：
美东时间 2025-10-30 盘后发布财报
|
| 2025-07-30 |
详情>>
业绩披露：
2025年中报每股收益1.06美元,归母净利润6272.80万美元,同比去年增长-1.94%
|
| 2025-04-24 |
详情>>
业绩披露：
2025年一季报每股收益0.51美元,归母净利润3014.70万美元,同比去年增长6.75%
|
| 2025-04-01 |
股东大会：
将于2025-05-14召开股东大会
会议内容 ▼▲
- 1.Elect four directors, each to serve until 2028
2.Non-binding, advisory vote to approve named executive officer compensation (“Say on Pay”)
3.Ratify appointment of Deloitte & Touche LLP as our independent registered public accounting firm
|
| 2025-02-25 |
详情>>
业绩披露：
2024年年报每股收益2.07美元,归母净利润1.20亿美元,同比去年增长27.48%
|
| 2025-02-25 |
详情>>
业绩披露：
2022年年报每股收益1.31美元,归母净利润7451.60万美元,同比去年增长53.79%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.59美元,归母净利润9241.00万美元,同比去年增长38.38%
|
| 2024-08-01 |
详情>>
业绩披露：
2023年中报每股收益0.71美元,归母净利润4094.80万美元,同比去年增长58.45%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益1.10美元,归母净利润6396.60万美元,同比去年增长56.21%
|
| 2024-04-30 |
详情>>
业绩披露：
2024年一季报每股收益0.49美元,归母净利润2824.00万美元,同比去年增长36.41%
|
| 2024-04-02 |
股东大会：
将于2024-05-15召开股东大会
会议内容 ▼▲
- 1.Elect three directors, each to serve until 2027
2.Non-binding, advisory vote to approve named executive officer compensation (“Say on Pay”)
3.Approve amendment to increase the number of shares authorized for issuance under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan
4.Ratify appointment of Deloitte & Touche LLP as our independent registered public accounting firm
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益1.64美元,归母净利润9441.10万美元,同比去年增长26.70%
|
| 2023-10-26 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.16美元,归母净利润6678.20万美元,同比去年增长62.43%
|
| 2023-04-04 |
股东大会：
将于2023-05-18召开股东大会
会议内容 ▼▲
- 1.Elect three directors, each to serve until 2026
2.Non-binding, advisory vote to approve named executive officer compensation (“Say on Pay”)
3.Non-binding, advisory vote on the frequency of votes on executive compensation
4.Ratify appointment of Deloitte & Touche LLP as our independent registered public accounting firm
|
| 2022-04-07 |
股东大会：
将于2022-05-19召开股东大会
会议内容 ▼▲
- 1.Elect four directors, each to serve until 2025
2.Non-binding, advisory vote to approve named executive officer compensation (“Say on Pay”)
3.Ratify appointment of Deloitte & Touche LLP as our independent registered public accounting firm
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-17召开股东大会
会议内容 ▼▲
- 1.Elect four directors, each to serve until 2024
2.Approve amendment to increase the number of shares authorized under the 2018 Long-Term Incentive Plan
3.Approve amendment to increase the number of shares authorized under the 1996 Employee Stock Purchase Plan
4.Non-binding, advisory vote to approve named executive officer compensation (“Say on Pay”)
5.Ratify appointment of independent registered public accounting firm (Deloitte&Touche)
|
| 2020-05-27 |
股东大会：
将于2020-06-22召开股东大会
会议内容 ▼▲
- 1.Elect three directors, each to serve until 2023
2.Non-binding advisory vote to approve named executive officer compensation (Say on Pay)
3.Ratify appointment of independent registered public accounting firm (Deloitte & Touche)
|
| 2020-03-16 |
复牌提示：
2020-03-16 09:45:21 停牌，复牌日期 2020-03-16 09:50:21
|
| 2019-04-11 |
股东大会：
将于2019-05-23召开股东大会
会议内容 ▼▲
- 1.Elect three directors, each to serve until 2022
2.Non-binding advisory vote to approve named executive officer compensation (Say on Pay)
3.Ratify appointment of independent registered public accounting firm (Deloitte & Touche)
|
| 2018-04-13 |
股东大会：
将于2018-05-24召开股东大会
会议内容 ▼▲
- 1.Elect three directors, each to serve until 2021
2.Amend Merit’s Articles of Incorporation to increase maximum Board size (from 9 to 11)
3.Non-binding advisory vote to approve named executive officer compensation (Say on Pay)
4.Approve our 2018 Long-Term Incentive Plan
5.Ratify appointment of independent registered public accounting firm (Deloitte & Touche)
|
| 2017-04-11 |
股东大会：
将于2017-05-24召开股东大会
会议内容 ▼▲
- (1)To elect three directors of the Company, to serve until the Annual Meeting of the Company’s Shareholders in 2020 and until their respective successors have been duly elected and qualified;
(2)To conduct an advisory vote on a non-binding resolution to approve the compensation of the Company’s named executive officers;
(3)To conduct an advisory vote on a non-binding resolution to determine whether, during the next six years, the Company’s shareholders will be asked to approve the compensation of the Company’s named executive officers every one, two or three years;
(4)To consider and vote upon a proposal to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2017;
(5)To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-04-11 |
股东大会：
将于2016-05-26召开股东大会
会议内容 ▼▲
- (1)To elect three directors of the Company, to serve until the Annual Meeting of the Company’s Shareholders in 2019 and until their respective successors have been duly elected and qualified;
(2)To conduct an advisory vote on a non-binding resolution to approve the compensation of the Company’s named executive officers;
(3)To consider and vote upon a proposal to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2016;
(4)To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|